CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated in patients with more than 8 days of macula-off rhegmatogenous retinal detachment, according to a study. A Fas inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback